Literature DB >> 12172986

High-resolution CT angiography of the abdomen.

C Catalano1, A Laghi, F Fraioli, F Pediconi, A Napoli, M Danti, R Passariello.   

Abstract

Multislice computed tomographic angiography (MSCTA) is a versatile technique that combines speed, excellent contrast, superb spatial resolution, and extreme simplicity. It has a wide range of applications in the abdomen including all vascular pathologies, occlusive or dilative, with excellent demonstration of atherosclerotic plaques in large or smaller branches. MSCTA is the method of choice in the follow-up of patients undergoing endovascular procedures for aneurysms. It provides excellent results in assessing vascular involvement by neoplasms arising from the liver, biliary tract, pancreas, kidneys, and all other abdominal organs. MSCTA can be used successfully in potential living donors and in the follow-up of recipients. Although MSCTA is a brand new technique, several developments are under investigation, which should allow further advancements in speed and spatial resolution.

Entities:  

Mesh:

Year:  2002        PMID: 12172986     DOI: 10.1007/s00261-001-0129-1

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  3 in total

1.  64-Slice multidetector row CT angiography of the abdomen: comparison of low versus high concentration iodinated contrast media in a porcine model.

Authors:  N-S Holalkere; K Matthes; S P Kalva; W R Brugge; D V Sahani
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

2.  Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma.

Authors:  L Schwartz; L Brody; K Brown; A Covey; S Tuorto; M Mazumdar; E Riedel; W Jarnagin; G Getrajdman; Y Fong
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

3.  Tumor feeding artery reconstruction with multislice spiral CT in the diagnosis of pelvic tumors of unknown origin.

Authors:  Hai-Jing Hu; Yong-Wen Huang; Ying-Chang Zhu
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.